[Effect of recombinant human tumor necrosis factor receptor type II-Fc fusion protein antibody on cytokines and bone metabolism in patients with juvenile idiopathic arthritis].
Li
Ling
L
Division of Rheumatology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
Zhang
Xiao
X
Cui
Yang
Y
Lu
Yi-yun
YY
Wang
Shu-xia
SX
Dong
Guang-fu
GF
Shi
Yun-zhen
YZ
Luo
Ri-qiang
RQ
Lei
Yun-xia
YX
D000293:Adolescent; D001171:Arthritis, Juvenile / Q000188:drug therapy / Q000378:metabolism*; D015519:Bone Density; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007141:Immunoglobulin Fc Fragments / Q000627:therapeutic use*; D007375:Interleukin-1 / Q000096:biosynthesis; D019278:Matrix Metalloproteinase 3 / Q000096:biosynthesis; D011446:Prospective Studies; D047889:Receptors, Tumor Necrosis Factor, Type II / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use
D007141:Immunoglobulin Fc Fragments; D007375:Interleukin-1; D047889:Receptors, Tumor Necrosis Factor, Type II; D011993:Recombinant Fusion Proteins; C511768:MMP3 protein, human; D019278:Matrix Metalloproteinase 3